title: APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer's disease.
abstract: Individuals carrying the *E4 allele of the apolipoprotein E gene (APOE) are at increased risk of developing Alzheimer's disease (AD). However, the biological mechanisms underlying this association are still unclear because of the complexity of the pathological processes that cause AD. Furthermore, the effect of APOE genotype on development, maintenance and aging of the normal brain is poorly understood because of the strong bias toward studying disease associations. In vivo techniques such as neuroimaging and cognitive testing offer valuable insights into the effects of APOE genotype on brain structure and function in healthy and clinical populations. We review the evidence from in vivo studies that APOE *E4, in addition to increasing the chance of age-related pathological events, is associated with age-independent non-pathological changes in brain physiology, some of which make the brain less resilient to neurodegenerative processes. We argue that the interaction between the APOE-dependent non-pathological vulnerabilities and age-related pathological changes is one mechanism that can trigger neurodegeneration, resulting in AD and other complex phenotypes.
authors.affiliation: Department of Psychology, University of Oslo, Box 1094, Blindern, 0317 Oslo, Norway. Electronic address: ivar.reinvang@psykologi.uio.no.
authors.forename: Ivar
authors.initials: I
authors.lastname: Reinvang
authors.forename: Thomas
authors.initials: T
authors.lastname: Espeseth
authors.forename: Lars Tjelta
authors.initials: LT
authors.lastname: Westlye
mesh_terms: D000375:Aging / Q000235:genetics* / Q000473:pathology; D000483:Alleles; D000544:Alzheimer Disease / Q000235:genetics* / Q000473:pathology; D001057:Apolipoproteins E / Q000235:genetics*; D015415:Biomarkers; D001921:Brain / Q000473:pathology*; D005838:Genotype; D006801:Humans; D059906:Neuroimaging
chemical_list: D001057:Apolipoproteins E; D015415:Biomarkers
keywords: AD; APOE; Alzheimer's disease; ApoE; AxD; CAA; CBF; CHRNA4; CSF; Cognition; DMN; DTI; FA; FC; FDG; GWAS; Imaging; MCI; MD; MRI; Mild cognitive impairment; Neurodegeneration; PET; PiB; Pittsburgh substance B; RD; RSNs; VBM; White matter integrity; apolipoprotein E gene; apolipoprotein E protein; axonal diffusivity; cerebral amyloid angiopathy; cerebral blood flow; cerebrospinal fluid; cholinergic receptor neural nicotinic alpha chain 4 gene; default-mode network; diffusion tensor imaging; fMRI; fluoride-deoxyglucose; fractional anisotropy; functional MRI; functional connectivity; genome wide association scan; magnetic resonance imaging; mean diffusivity; mild cognitive impairment; nbM; nucleus basalis Meynert; positron emission tomography; radial diffusivity; resting state networks; voxel based morphometry